GLP-1

According to the complaint, defendants benefited financially after manufacturers inflated prices for insulin and related meds, then paid rebates to PBMs in exchange for preferred formulary placement.

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.